EUVIMEDOpdag EUVIMED
Open access · CC BY-NC 4.0

Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention

Jang-Whan Bae

Cardiovascular Prevention and Pharmacotherapy · 2019

DOI: 10.36011/cpp.2019.1.e1 ↗

At a glance

Journal article in Cardiovascular Prevention and Pharmacotherapy, 2019. Written by Jang-Whan Bae. Cited 1 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Cite

APA

Bae, J. (2019). Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. https://doi.org/10.36011/cpp.2019.1.e1

Vancouver

Bae J. Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention. Cardiovascular Prevention and Pharmacotherapy. 2019. doi:10.36011/cpp.2019.1.e1

BibTeX
@article{Bae2019,
  author = {Bae, Jang-Whan},
  title = {Role of Novel Oral Anticoagulant for Patient with Atrial Fibrillation Underwent Percutaneous Coronary Intervention},
  journal = {Cardiovascular Prevention and Pharmacotherapy},
  year = {2019},
  doi = {10.36011/cpp.2019.1.e1}
}
Start for free →